Aurora Cannabis Inc. (NASDAQ:ACB – Get Free Report) was the recipient of a significant decline in short interest in the month of June. As of June 30th, there was short interest totalling 3,840,000 shares, a decline of 7.0% from the June 15th total of 4,130,000 shares. Based on an average daily trading volume, of 4,650,000 shares, the days-to-cover ratio is currently 0.8 days. Approximately 7.1% of the shares of the company are short sold.
Aurora Cannabis Stock Performance
Shares of ACB opened at $5.94 on Thursday. The firm has a market cap of $324.03 million, a PE ratio of -4.24 and a beta of 1.86. The stock’s fifty day moving average price is $5.92 and its two-hundred day moving average price is $5.14. The company has a debt-to-equity ratio of 0.08, a current ratio of 3.42 and a quick ratio of 1.93. Aurora Cannabis has a 1 year low of $2.84 and a 1 year high of $11.50.
Aurora Cannabis (NASDAQ:ACB – Get Free Report) last announced its quarterly earnings results on Thursday, June 20th. The company reported $0.11 earnings per share for the quarter, beating the consensus estimate of ($0.18) by $0.29. The company had revenue of $49.98 million during the quarter, compared to analysts’ expectations of $51.28 million. Aurora Cannabis had a negative return on equity of 9.34% and a negative net margin of 26.97%. On average, equities research analysts forecast that Aurora Cannabis will post -0.5 EPS for the current year.
Hedge Funds Weigh In On Aurora Cannabis
About Aurora Cannabis
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Featured Stories
- Five stocks we like better than Aurora Cannabis
- What Does Downgrade Mean in Investing?
- Real Estate Stock Signals a Boom in Manufacturing Activity
- Stock Average Calculator
- This Medical Giant’s Stock Rebounds: A 15% Upside Is the Minimum
- Best Stocks Under $5.00
- Financial Giant’s Shares Soar on EPS Beat and Record Asset Levels
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.